XML 44 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Equity (USD $)
Total
Series B Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Total NeoStem, Inc. Shareholders' Equity [Member]
Non-Controlling Interest in Subsidiary [Member]
Beginning Balance at Dec. 31, 2011 $ 80,132,518 $ 100 $ 109,330 $ 200,858,638 $ 4,152,343 $ (143,094,854) $ 62,025,557 $ 18,106,961
Beginning Balance (in shares) at Dec. 31, 2011   10,000 109,329,587          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (51,025,744) 0 0 0 0 (38,264,381) (38,264,381) (12,761,363)
Foreign currency translation 147,301 0 0 0 (3,576) 0 (3,576) 150,877
Share-based compensation (in shares)   0 2,634,028          
Share-based compensation 5,471,166 0 2,634 5,468,532 0 0 5,471,166 0
Proceeds from issuance of common stock (in shares)   0 28,765,623          
Proceeds from issuance of common stock 12,160,227 0 28,766 12,131,461 0 0 12,160,227 0
Proceeds from warrant exercises (in shares)     10,160,521          
Proceeds from warrant exercises 5,925,931   10,160 5,915,771     5,925,931  
Repayment of Series E Preferred Principal and Dividends (in shares)   0 2,792,375          
Repayment of Series E Preferred Principal and Dividends 938,785 0 2,792 1,199,425 0 (263,432) 938,785 0
Warrant inducements (in shares)     1,458,952          
Warrant inducements (43,716)   1,459 (45,175)   0 (43,716)  
Ending Balance at Sep. 30, 2012 $ 53,706,468 $ 100 $ 155,141 $ 225,528,652 $ 4,148,767 $ (181,622,667) $ 48,209,993 $ 5,496,475
Ending Balance (in shares) at Sep. 30, 2012   10,000 155,141,086